Evidence map›Paper›PMID 31390044›Full record

ArticleJournal of the American Geriatrics Society2019

Measuring Underuse and Overuse of Medications.

Joseph T Hanlon, Kenneth E Schmader

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Journal of the American Geriatrics Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Reply to Measuring Under- and Over-Use of Medications.Journal of the American Geriatrics Society · 2019
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Joseph T HanlonDepartment of Medicine (Geriatrics), School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
Kenneth E SchmaderDepartment of Medicine (Geriatrics), School of Medicine, Duke University Medical Center, Durham, North Carolina.

Funding

Resource Core 3 - Metabolomics CoreP30AG028716 · NIA · DUKE UNIVERSITY · PI Sarah B. Peskoe · 2006 to 2026
$24.6M
Addressing Behavior and Mood in Assisted Living: Organizational Characteristics Related to the Use of Antipsychotic and Psychotropic Medications and Alternative PracticesR01AG050602 · NIA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ZIMMERMAN, SHERYL · 2015 to 2019
$3.9M
Pilot Study of Standardized PatiEnt-CenTered medicatiOn Review (SPECTORx) in Home HospiceR21AG060017 · NIA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI TJIA, JENNIFER · 2018 to 2019
$481k
Reducing High-Risk Geriatric Polypharmacy via EHR NudgesR21AG057396 · NIA · RAND CORPORATION · PI FRIEDBERG, MARK WILLIAM · 2017 to 2018
$455k
Agency for Healthcare Research and Quality R18-HS023779Health Services Research and Development IIR 14-306Health Services Research and Development IR 15-115NIA NIH HHS P30 AG028716NIA NIH HHS P30AG028716NIA NIH HHS R01AG050602NIA NIH HHS R21AG057396NIA NIH HHS R21AG060017
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Health StatusPolypharmacy

Identifiers

PMID31390044

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.